Considerations for widespread implementation of blood-based biomarkers of Alzheimer's disease. Mielke MM, Anderson M, Ashford JW, Jeromin A, et al. Alzheimers Dement 2024 Oct 6. doi: 10.1002/alz.14150.

Read + Share

Amedeo Smart

Independent Medical Education

Mielke MM, Anderson M, Ashford JW, Jeromin A, et al. Considerations for widespread implementation of blood-based biomarkers of Alzheimer's disease. Alzheimers Dement 2024 Oct 6. doi: 10.1002/alz.14150.
PMID: 39369283